Page last updated: 2024-09-05

tau 284 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

tau 284 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies

Compound Research Comparison

Studies
(tau 284)
Trials
(tau 284)
Recent Studies (post-2010)
(tau 284)
Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
5218219,156187552

Protein Interaction Comparison

ProteinTaxonomytau 284 (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inagaki, N; Koda, A; Nagai, H; Ueno, M1
Atsumi, I; Fujii, A; Iemura, M; Kida, T; Sakai, O; Sakaki, H; Wada, T1

Other Studies

2 other study(ies) available for tau 284 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
    Pharmacology, 1998, Volume: 57, Issue:4

    Topics: Animals; Anti-Allergic Agents; Asthma; Bronchoconstriction; Disease Models, Animal; Eosinophilia; Eosinophils; Female; Guinea Pigs; Histamine H1 Antagonists; Hypersensitivity; Ketotifen; Male; Passive Cutaneous Anaphylaxis; Piperidines; Platelet Activating Factor; Pyridines; Rats; Rats, Wistar

1998
Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Experimental eye research, 2010, Volume: 91, Issue:1

    Topics: Animals; Capillary Permeability; Cells, Cultured; Chemotaxis, Leukocyte; Conjunctiva; Conjunctivitis, Allergic; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophils; Guinea Pigs; Histamine; Histamine H1 Antagonists; Histamine Release; Leukotriene B4; Male; Mast Cells; Ovalbumin; Peritoneal Cavity; Piperidines; Platelet Activating Factor; Pyridines; Rats; Rats, Wistar

2010